Oncolytics Biotech, Inc. Common Shares (ONCY) is a publicly traded Healthcare sector company. As of October 27, 2026, ONCY trades at $0.48 with a market cap of $65.86M and a P/E ratio of -2.01. ONCY moved +1.39% today. Year to date, ONCY is -51.90%; over the trailing twelve months it is -60.57%. Its 52-week range spans $0.33 to $1.51. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces ONCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover ONCY: 0 strong buy, 2 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.00.
| Metric | Value |
|---|---|
| Price | $0.48 |
| Market Cap | $65.86M |
| P/E Ratio | -2.01 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.51 |
| 52-Week Low | $0.33 |
| Volume | 569.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.76M |
| Gross Margin | 0.00% |
3 analysts cover ONCY: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.